TrialPanorama/TrialPanorama-database huggingface dataset:
Study 28213783 — Predictive Biomarker (PRD); Safety Biomarker (SAF): Cellular tumor antigen p53
Genes: TP53; P53
Study 25458745 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study 25458745 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study 25458745 — Predictive Biomarker (PRD): FCGR3B
Genes: CD16; CD16b; FcgammaRIIIb; FcRIIIb
Study 30131099 — Surrogate Endpoint (SUR): Blood pressure
Study 25834495 — Predictive Biomarker (PRD): PTBP2 mRNA
Genes: PTBP2; NPTB; PTB; PTBLP
Study 15677625 — Predictive Biomarker (PRD): Estrogen receptor
Genes: ESR1; ESR; NR3A1
Study 12407637 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Monitoring Biomarker (MOI): Vitamin B12
Study 26715763 — Predictive Biomarker (PRD): STS mRNA
Genes: STS; ARSC1
Study 26715763 — Surrogate Endpoint (SUR): Blood pressure
Study 17264781 — Safety Biomarker (SAF): Thyroid stimulating hormone
Study 7903217 — Pharmacodynamic Biomarker (PDY): Angiotensin-converting enzyme
Genes: ACE; DCP; DCP1
Study 9252721 — Predictive Biomarker (PRD); Safety Biomarker (SAF): HLA-A
Study 16463811 — Surrogate Endpoint (SUR): Blood pressure
Study 29052340 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study 18241749 — Predictive Biomarker (PRD): GAST mRNA
Genes: GAST; GAS
Study 6215056 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY): Free fatty acids
Study 8751029 — Pharmacodynamic Biomarker (PDY): Angiotensin-converting enzyme
Genes: ACE; DCP; DCP1
Study 29948216 — Safety Biomarker (SAF): Reactive oxygen species
Study 7916183 — Predictive Biomarker (PRD); Safety Biomarker (SAF): White blood cell
Study 28343658 — Monitoring Biomarker (MOI): Tissue transglutaminase
Genes: TGM2
Study 15333422 — Pharmacodynamic Biomarker (PDY): Low-density lipoprotein
Study 9024246 — Pharmacodynamic Biomarker (PDY): Valproic acid
Study 3056447 — Surrogate Endpoint (SUR): Blood pressure
Study 16856621 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study 8416660 — Pharmacodynamic Biomarker (PDY): High density lipoprotein cholesterol
Study 18295937 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study 18295937 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study 18295937 — Safety Biomarker (SAF): von Willebrand factor
Genes: VWF; F8VWF
Study 18295937 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Interleukin 6
Genes: IL6; IFNB2
Study 18295937 — Safety Biomarker (SAF): Plasminogen activator inhibitor
Genes: SERPINE1; PAI1; PLANH1
Study 10814771 — Pharmacodynamic Biomarker (PDY): Homovanillic acid
Study 31888234 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study 31888234 — Pharmacodynamic Biomarker (PDY): Low-density lipoprotein
Study 1369705 — Surrogate Endpoint (SUR): Blood pressure
Study 15657588 — Surrogate Endpoint (SUR): Bone mineral density
Study 15657588 — Surrogate Endpoint (SUR): Serum calcium
Study 9475316 — Pharmacodynamic Biomarker (PDY): Superoxide dismutase Cu-Zn
Genes: SOD1
Study 2884858 — Surrogate Endpoint (SUR): Blood pressure
Study 14554218 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study 27908164 — Predictive Biomarker (PRD): FBP1 mRNA
Genes: FBP1; FBP
Study 22403352 — Surrogate Endpoint (SUR): Blood pressure
Study 10420094 — Predictive Biomarker (PRD): POMC
Genes: MSH; POC; CLIP; ACTH; NPP; LPH
Study 22286364 — Predictive Biomarker (PRD): LPP mRNA
Genes: LPP
Study 17377905 — Safety Biomarker (SAF): IL-6 and IL-10
Study 11593093 — Surrogate Endpoint (SUR): Blood pressure
Study 30830672 — Predictive Biomarker (PRD): LEP mRNA
Genes: LEP; OB; OBS
Study 19332211 — Surrogate Endpoint (SUR): Blood pressure
Study 15764956 — Safety Biomarker (SAF): PPOX
Genes: HCRT; OX
Study 8704435 — Predictive Biomarker (PRD): EP300 mRNA
Genes: EP300; P300
Study 21537155 — Pharmacodynamic Biomarker (PDY): Angiotensin-converting enzyme
Genes: ACE; DCP; DCP1
Study 21537155 — Safety Biomarker (SAF): ACE
Genes: ACE1; CD143
Study 16226163 — Pharmacodynamic Biomarker (PDY): Low-density lipoprotein
Study 17299195 — Pharmacodynamic Biomarker (PDY): Low-density lipoprotein
Study 8432669 — Predictive Biomarker (PRD); Safety Biomarker (SAF): Lactate dehydrogenase
Study 9060545 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study 9060545 — Safety Biomarker (SAF): Interleukin 2
Genes: IL2
Study 3720755 — Surrogate Endpoint (SUR): Blood pressure
Study 29131079 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study 27759486 — Surrogate Endpoint (SUR): Bone mineral density
Study 25173606 — Surrogate Endpoint (SUR): Bone mineral density
Study 20837847 — Safety Biomarker (SAF): Interleukin 12
Study 15078749 — Predictive Biomarker (PRD): FEV mRNA
Genes: FEV; PET1
Study 10792152 — Surrogate Endpoint (SUR): Blood pressure
Study 25568079 — Predictive Biomarker (PRD): CCK mRNA
Genes: CCK
Study 25568079 — Predictive Biomarker (PRD): PYY mRNA
Genes: PYY
Study 15558528 — Surrogate Endpoint (SUR): Serum calcium
Study 9381772 — Safety Biomarker (SAF): Hyaluronic acid
Study 26679695 — Surrogate Endpoint (SUR): Blood pressure
Study 20955582 — Predictive Biomarker (PRD): ARCN1 mRNA
Genes: ARCN1; COPD
Study 7636894 — Surrogate Endpoint (SUR): Blood pressure
Study 2526172 — Safety Biomarker (SAF): DRD2
Study 31541606 — Surrogate Endpoint (SUR): Blood pressure
Study 21807323 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Interleukin 6
Genes: IL6; IFNB2
Study 3230152 — Pharmacodynamic Biomarker (PDY): Angiotensin-converting enzyme
Genes: ACE; DCP; DCP1
Study 30782930 — Pharmacodynamic Biomarker (PDY): Angiotensin-converting enzyme
Genes: ACE; DCP; DCP1
Study 30782930 — Surrogate Endpoint (SUR): Blood pressure
Study 21128991 — Predictive Biomarker (PRD): PLXNA2 mRNA
Genes: PLXNA2; KIAA0463; OCT; PLXN2; UNQ209/PRO235
Study 27909035 — Predictive Biomarker (PRD): CPTP mRNA
Genes: CPTP; GLTPD1
Study 15502720 — Predictive Biomarker (PRD): C2 mRNA
Genes: C2
Study 20386063 — Surrogate Endpoint (SUR): Blood pressure
Study 18316526 — Predictive Biomarker (PRD): CYP3A4 mRNA
Genes: CYP3A4; CYP3A3
Study 12439090 — Surrogate Endpoint (SUR): Bone mineral density
Study 6384072 — Surrogate Endpoint (SUR): Blood pressure
Study 26700848 — Predictive Biomarker (PRD): AMH mRNA
Genes: AMH; MIF
Study 18018468 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study 7836703 — Predictive Biomarker (PRD): PBX1 mRNA
Genes: PBX1; PRL
Study 29756523 — Pharmacodynamic Biomarker (PDY): High density lipoprotein cholesterol
Study 1105628 — Pharmacodynamic Biomarker (PDY): Homovanillic acid
Study 25465711 — Safety Biomarker (SAF): Hyaluronic acid
Study 17378196 — Surrogate Endpoint (SUR): Serum uric acid
Study 15126927 — Surrogate Endpoint (SUR): Blood pressure
Study 29029193 — Pharmacodynamic Biomarker (PDY): Fibroblast growth factor 23
Genes: FGF23; HYPF; UNQ3027/PRO9828
Study 17972380 — Predictive Biomarker (PRD): ARSB mRNA
Genes: ARSB
Study 16376756 — Predictive Biomarker (PRD): TG mRNA
Genes: TG
Study 23866812 — Predictive Biomarker (PRD): FHL5 mRNA
Genes: FHL5; ACT
Study 22856526 — Surrogate Endpoint (SUR): Sperm parameters
Study 30206162 — Predictive Biomarker (PRD): Phosphatase and tensin homolog
Genes: PTEN; MMAC1; TEP1
Study 30206162 — Predictive Biomarker (PRD): AR mRNA
Genes: AR; DHTR; NR3C4
Study 6818867 — Surrogate Endpoint (SUR): Blood pressure
Study 30910544 — Surrogate Endpoint (SUR): Blood pressure
Study 30910544 — Safety Biomarker (SAF): Thyroid stimulating hormone
Study 15793171 — Surrogate Endpoint (SUR): Blood pressure
Study 26024521 — Pharmacodynamic Biomarker (PDY): Fibroblast growth factor 23
Genes: FGF23; HYPF; UNQ3027/PRO9828
Study 23705968 — Surrogate Endpoint (SUR): Blood pressure
Study 22278623 — Surrogate Endpoint (SUR): Blood pressure
Study 9219699 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study 27464467 — Predictive Biomarker (PRD); Safety Biomarker (SAF): CAT mRNA
Genes: CAT
Study 20463641 — Predictive Biomarker (PRD): SRL mRNA
Genes: SRL
Study 12660312 — Surrogate Endpoint (SUR): Blood pressure
Study 8862490 — Pharmacodynamic Biomarker (PDY): Low-density lipoprotein
Study 8862490 — Pharmacodynamic Biomarker (PDY): High density lipoprotein cholesterol
Study 1640854 — Predictive Biomarker (PRD): SI mRNA
Genes: SI
Study 1640854 — Predictive Biomarker (PRD): NUCB2 mRNA
Genes: NUCB2; NEFA
Study 22700685 — Safety Biomarker (SAF); Monitoring Biomarker (MOI): Neutrophil gelatinase-associated lipocalin
Genes: LCN2; HNL; NGAL
Study 10701814 — Surrogate Endpoint (SUR): Blood pressure
Study 9269703 — Surrogate Endpoint (SUR): Blood pressure
Study 8443032 — Predictive Biomarker (PRD): TG mRNA
Genes: TG
Study 8443032 — Surrogate Endpoint (SUR): Blood pressure
Study 3535357 — Pharmacodynamic Biomarker (PDY): Low-density lipoprotein
Study 28004200 — Predictive Biomarker (PRD): Zinc finger protein GLI1
Genes: GLI1; GLI
Study 1592277 — Predictive Biomarker (PRD): CP mRNA
Genes: CP
Study 1592277 — Predictive Biomarker (PRD): CAP1 mRNA
Genes: CAP1; CAP
Study 30469412 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study 21313926 — Predictive Biomarker (PRD): MB mRNA
Genes: MB
Study 21313926 — Predictive Biomarker (PRD): ITGB2 mRNA
Genes: ITGB2; CD18; MFI7
Study 24955613 — Predictive Biomarker (PRD): RB1
Genes: RB; PPP1R130
Study 24955613 — Surrogate Endpoint (SUR): Blood pressure
Study 24955613 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study 24955613 — Pharmacodynamic Biomarker (PDY): Low-density lipoprotein
Study 19938965 — Predictive Biomarker (PRD): FEV mRNA
Genes: FEV; PET1
Study 19938965 — Predictive Biomarker (PRD): ARCN1 mRNA
Genes: ARCN1; COPD
Study 17523342 — Safety Biomarker (SAF): Cytochrome P450 2C19
Genes: CYP2C19
Study 31817936 — Surrogate Endpoint (SUR): Blood pressure
Study 12665408 — Surrogate Endpoint (SUR): Blood pressure
Study 10416459 — Surrogate Endpoint (SUR): Blood pressure
Study 31924277 — Surrogate Endpoint (SUR): Blood pressure
Study 29199100 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study 24395288 — Surrogate Endpoint (SUR): Bone mineral density
Study 20332588 — Pharmacodynamic Biomarker (PDY): Dipeptidyl peptidase 4
Genes: DPP4; ADCP2; CD26
Study 7751881 — Predictive Biomarker (PRD): COMP mRNA
Genes: COMP
Study 26219161 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study 21812889 — Pharmacodynamic Biomarker (PDY): Low-density lipoprotein
Study 21812889 — Pharmacodynamic Biomarker (PDY): High density lipoprotein cholesterol
Study 16449339 — Surrogate Endpoint (SUR): Bone mineral density
Study 11035889 — Predictive Biomarker (PRD): CIT mRNA
Genes: CIT; CRIK; KIAA0949; STK21
Study 8848410 — Predictive Biomarker (PRD): NPY mRNA
Genes: NPY
Study 8848410 — Safety Biomarker (SAF): Natriuretic peptides A
Genes: NPPA; ANP; PND
Study 8848410 — Safety Biomarker (SAF); Monitoring Biomarker (MOI): Endothelin-1
Genes: EDN1
Study 6825123 — Surrogate Endpoint (SUR): Serum calcium
Study 26077241 — Predictive Biomarker (PRD); Safety Biomarker (SAF): PIK3CA
Genes: PI3K
Study 16423633 — Pharmacodynamic Biomarker (PDY): Low-density lipoprotein
Study 16423633 — Pharmacodynamic Biomarker (PDY): High density lipoprotein cholesterol
Study 16423633 — Surrogate Endpoint (SUR): Blood pressure
Study 16423633 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Monitoring Biomarker (MOI): Vitamin B12
Study 16423633 — Surrogate Endpoint (SUR): Serum creatinine
Study 15265190 — Pharmacodynamic Biomarker (PDY): Valproic acid
Study 15265190 — Surrogate Endpoint (SUR): Bone mineral density
Study 15265190 — Surrogate Endpoint (SUR): Serum calcium
Study 9524832 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study 23884387 — Surrogate Endpoint (SUR): Blood pressure
Study 18423869 — Predictive Biomarker (PRD): CFH mRNA
Genes: CFH; HF; HF1; HF2
Study 8668059 — Predictive Biomarker (PRD): HR mRNA
Genes: HR
Study 8668059 — Predictive Biomarker (PRD): SELENBP1 mRNA
Genes: SELENBP1; SBP
Study 8668059 — Surrogate Endpoint (SUR): Blood pressure
Study 7395772 — Surrogate Endpoint (SUR): Serum triglycerides
Study 22244567 — Predictive Biomarker (PRD); Safety Biomarker (SAF): Interleukin 8
Genes: CXCL8; IL8
Study 22244567 — Safety Biomarker (SAF): B-type natriuretic peptide
Genes: NPPB
Study 22244567 — Safety Biomarker (SAF): Cardiac troponin I
Genes: TNNI3; TNNC1
Study 2140325 — Safety Biomarker (SAF): Natriuretic peptides A
Genes: NPPA; ANP; PND
Study 29895590 — Surrogate Endpoint (SUR): Blood pressure
Study 23058854 — Surrogate Endpoint (SUR): Serum creatinine
Study 10726009 — Safety Biomarker (SAF): von Willebrand factor
Genes: VWF; F8VWF
Study 22765882 — Surrogate Endpoint (SUR): Blood pressure
Study 29575386 — Predictive Biomarker (PRD): PTBP2 mRNA
Genes: PTBP2; NPTB; PTB; PTBLP
Study 14562993 — Surrogate Endpoint (SUR): Bone mineral density
Study 22378291 — Predictive Biomarker (PRD): PPARG mRNA
Genes: PPARG; NR1C3
Study 22378291 — Safety Biomarker (SAF): Peroxisome proliferator-activated receptor alpha
Genes: PPARA
Study 28238195 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Vascular endothelial growth factor A
Genes: VEGFA; VEGF
Study 15553604 — Predictive Biomarker (PRD): CS mRNA
Genes: CS
Study 9444446 — Surrogate Endpoint (SUR): Blood pressure
Study 19614943 — Surrogate Endpoint (SUR): Blood pressure
Study 16861090 — Pharmacodynamic Biomarker (PDY): Low-density lipoprotein
Study 16861090 — Pharmacodynamic Biomarker (PDY): High density lipoprotein cholesterol
Study 17651144 — Predictive Biomarker (PRD): GSTM1 mRNA
Genes: GSTM1; GST1
Study 17651144 — Safety Biomarker (SAF): Glutathione S-transferase P
Genes: GSTP1; FAEES3; GST3
Study 10424293 — Surrogate Endpoint (SUR): Serum alkaline phosphatase
Study 19302902 — Predictive Biomarker (PRD); Safety Biomarker (SAF): White blood cell
Study 8712383 — Predictive Biomarker (PRD); Safety Biomarker (SAF): White blood cell
Study 11039135 — Surrogate Endpoint (SUR): Blood pressure
Study 1655177 — Surrogate Endpoint (SUR): Serum alkaline phosphatase
Study 1655177 — Surrogate Endpoint (SUR): Serum calcium
Study 22262484 — Predictive Biomarker (PRD): Arginine vasopressin
Genes: AVP; ARVP; VP
Study 22262484 — Pharmacodynamic Biomarker (PDY): Angiotensinogenase renin
Genes: REN
Study 22262484 — Safety Biomarker (SAF): Natriuretic peptides A
Genes: NPPA; ANP; PND
Study 17524265 — Monitoring Biomarker (MOI): HBV DNA
Study 12077732 — Predictive Biomarker (PRD): SHBG mRNA
Genes: SHBG
Study 21439546 — Safety Biomarker (SAF): von Willebrand factor
Genes: VWF; F8VWF
Study 19436663 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study 19436663 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study 19436663 — Pharmacodynamic Biomarker (PDY): Low-density lipoprotein
Study 19436663 — Pharmacodynamic Biomarker (PDY): High density lipoprotein cholesterol
Study 9806655 — Predictive Biomarker (PRD); Safety Biomarker (SAF): TP53
Genes: p53; LFS1
Study 24768657 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study 12364460 — Predictive Biomarker (PRD): GHR mRNA
Genes: GHR
Study 18608103 — Surrogate Endpoint (SUR): Forced vital capacity
Study 647213 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY): Free fatty acids
Study 647213 — Surrogate Endpoint (SUR): Serum potassium
Study 29462095 — Pharmacodynamic Biomarker (PDY): High density lipoprotein cholesterol
Study 29462095 — Pharmacodynamic Biomarker (PDY): Low-density lipoprotein
Study 24738516 — Pharmacodynamic Biomarker (PDY): High density lipoprotein cholesterol
Study 24738516 — Pharmacodynamic Biomarker (PDY): Low-density lipoprotein
Study 18422205 — Predictive Biomarker (PRD); Safety Biomarker (SAF): DES mRNA
Genes: DES
Study 29801123 — Safety Biomarker (SAF): Complement factor D
Genes: CFD; DF; PFD
Study 20013816 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study 1496965 — Pharmacodynamic Biomarker (PDY): Angiotensin-converting enzyme
Genes: ACE; DCP; DCP1
Study 31215460 — Predictive Biomarker (PRD): TG mRNA
Genes: TG
Study 27608437 — Predictive Biomarker (PRD): SV2A mRNA
Genes: SV2A; KIAA0736; PSEC0174
Study 16386522 — Predictive Biomarker (PRD); Safety Biomarker (SAF): Interleukin 2 receptor alpha
Genes: IL2RA
Study 16386522 — Surrogate Endpoint (SUR): Serum creatinine
Study 9930597 — Predictive Biomarker (PRD); Safety Biomarker (SAF): Immunoglobulin E
Study 24866022 — Predictive Biomarker (PRD); Safety Biomarker (SAF): White blood cell
Study 24866022 — Pharmacodynamic Biomarker (PDY): Superoxide dismutase Cu-Zn
Genes: SOD1
Study 24866022 — Safety Biomarker (SAF): Reactive oxygen species
Study 18064446 — Safety Biomarker (SAF): Beta-2-microglobulin
Genes: B2M; CDABP0092; HDCMA22P
Study 18064446 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY): Serum albumin
Genes: ALB; GIG20; GIG42; PRO0903; PRO1708; PRO2044; PRO2619; PRO2675; UNQ696/PRO1341
Study 16055569 — Predictive Biomarker (PRD): BPI mRNA
Genes: BPI
Study 12658791 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study 10512925 — Safety Biomarker (SAF): MTHFR
Study 26669430 — Surrogate Endpoint (SUR): Blood pressure
Study 22621166 — Predictive Biomarker (PRD): Vitamin D-binding protein
Genes: GC
Study 20954960 — Surrogate Endpoint (SUR): Blood pressure
Study 17388962 — Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): TNF related activation protein
Genes: CD40LG; CD40L; TNFSF5; TRAP
Study 17388962 — Pharmacodynamic Biomarker (PDY): Low-density lipoprotein
Study 28054262 — Predictive Biomarker (PRD): PC mRNA
Genes: PC
Study 8461219 — Predictive Biomarker (PRD): Arginine vasopressin
Genes: AVP; ARVP; VP
Study 3026294 — Pharmacodynamic Biomarker (PDY): Angiotensin-converting enzyme
Genes: ACE; DCP; DCP1
Study 3026294 — Surrogate Endpoint (SUR): Blood pressure
Study 29291887 — Predictive Biomarker (PRD): HR mRNA
Genes: HR
Study 29291887 — Surrogate Endpoint (SUR): Blood pressure
Study 15781429 — Predictive Biomarker (PRD): TG mRNA
Genes: TG
Study 7073415 — Pharmacodynamic Biomarker (PDY): Low-density lipoprotein
Study 7073415 — Pharmacodynamic Biomarker (PDY): High density lipoprotein cholesterol
Study 29653915 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study 10197230 — Surrogate Endpoint (SUR): Blood pressure
Study 30595565 — Surrogate Endpoint (SUR): Serum calcium
Study 27488472 — Predictive Biomarker (PRD): SRI mRNA
Genes: SRI
Study 17932136 — Surrogate Endpoint (SUR): Blood pressure
Study 20679736 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study 12212785 — Predictive Biomarker (PRD): MCIDAS mRNA
Genes: MCIDAS; IDAS; MCI; MCIN
Study 10099033 — Surrogate Endpoint (SUR): Blood pressure
Study 10099033 — Pharmacodynamic Biomarker (PDY): Angiotensin-converting enzyme
Genes: ACE; DCP; DCP1
Study 7001207 — Surrogate Endpoint (SUR): Blood pressure
Study 23467363 — Predictive Biomarker (PRD): TES mRNA
Genes: TES
Study 19843667 — Surrogate Endpoint (SUR): Cervical intraepithelial neoplasia
Study 29258549 — Predictive Biomarker (PRD): EBF1 mRNA
Genes: EBF1; COE1; EBF
Study 23550861 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study 21324167 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study 9159038 — Surrogate Endpoint (SUR): Serum creatinine
Study 16429299 — Predictive Biomarker (PRD): TG mRNA
Genes: TG
Study 17290061 — Predictive Biomarker (PRD): CS mRNA
Genes: CS
Study 23620949 — Predictive Biomarker (PRD): PC mRNA
Genes: PC
Study 12671829 — Pharmacodynamic Biomarker (PDY): Low-density lipoprotein
Study 12671829 — Pharmacodynamic Biomarker (PDY): High density lipoprotein cholesterol
Study 12671829 — Surrogate Endpoint (SUR): Serum calcium
Study 31935026 — Predictive Biomarker (PRD): NPEPPS mRNA
Genes: NPEPPS; PSA
Study 14747042 — Predictive Biomarker (PRD): NPEPPS mRNA
Genes: NPEPPS; PSA
Study 9177894 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study 8263885 — Surrogate Endpoint (SUR): Blood pressure
Study 31780023 — Predictive Biomarker (PRD): SI mRNA
Genes: SI
Study 6807081 — Pharmacodynamic Biomarker (PDY): Valproic acid
Study 19139851 — Pharmacodynamic Biomarker (PDY): Superoxide dismutase Cu-Zn
Genes: SOD1
Study 19139851 — Safety Biomarker (SAF): Interleukin 2
Genes: IL2
Study 12841346 — Pharmacodynamic Biomarker (PDY): High density lipoprotein cholesterol
Study 12841346 — Pharmacodynamic Biomarker (PDY): Low-density lipoprotein
Study 21448726 — Predictive Biomarker (PRD): TG mRNA
Genes: TG
Study 19195512 — Surrogate Endpoint (SUR): Serum creatinine
Study 1770473 — Surrogate Endpoint (SUR): Blood pressure
Study 29222893 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY): Free fatty acids
Study 24523436 — Predictive Biomarker (PRD): MIP mRNA
Genes: MIP; AQP0
Study 24523436 — Predictive Biomarker (PRD): CCL18 mRNA
Genes: CCL18; AMAC1; DCCK1; MIP4; PARC; SCYA18
Study 24523436 — Predictive Biomarker (PRD): CD46 mRNA
Genes: CD46; MCP; MIC10
Study 24523436 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study 17907107 — Predictive Biomarker (PRD): PPARA mRNA
Genes: PPARA; NR1C1; PPAR
Study 16045858 — Surrogate Endpoint (SUR): Bone mineral density
Study 8635058 — Surrogate Endpoint (SUR): Bone mineral density
Study 2127226 — Surrogate Endpoint (SUR): Blood pressure
Study 22085316 — Pharmacodynamic Biomarker (PDY): Low-density lipoprotein
Study 19088267 — Predictive Biomarker (PRD): CXCR3 mRNA
Genes: CXCR3; GPR9
Study 11528360 — Predictive Biomarker (PRD): Ki-67
Genes: MKI67; MIB-1; PPP1R105
Study 7522899 — Predictive Biomarker (PRD): CD34 mRNA
Genes: CD34
Study 7522899 — Safety Biomarker (SAF): Granulocyte-macrophage colony-stimulating factor
Genes: CSF2; GMCSF
Study 26600645 — Pharmacodynamic Biomarker (PDY): Angiotensin-converting enzyme
Genes: ACE; DCP; DCP1
Study 6430811 — Surrogate Endpoint (SUR): Blood pressure
Study 27161974 — Predictive Biomarker (PRD): Estrogen receptor
Genes: ESR1; ESR; NR3A1
Study 22446170 — Predictive Biomarker (PRD): SLC5A2 mRNA
Genes: SLC5A2; SGLT2
Study 20181810 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study 20181810 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY): Free fatty acids
Study 11715356 — Pharmacodynamic Biomarker (PDY): Angiotensin-converting enzyme
Genes: ACE; DCP; DCP1
Study 11715356 — Safety Biomarker (SAF); Monitoring Biomarker (MOI): Endothelin-1
Genes: EDN1
Study 825821 — Predictive Biomarker (PRD): CBS mRNA
Genes: CBS